Showing 1 - 2 results of 2 for search 'Qingqing Leng', query time: 0.03s Refine Results
  1. 1
    Case Report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment

    Case Report: Combined PD-1 and tyrosine kinase blockade stabilizes refractory pancreatic cancer guided by the spatial structure of tumor immune microenvironment by Heqi Yang, Heqi Yang, Yuhang Ma, Yuhang Ma, Chenyan Zhang, Chenyan Zhang, Qingqing Leng, Qingqing Leng, Ke Cheng, Ke Cheng, Chengjian Zhao, Dan Cao, Dan Cao

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective phase Ib/II trial

    HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective phase Ib/II trial by Qingqing Leng, Jitao Zhou, Xin Wang, Pei Zhang, Huanji Xu, Dan Cao

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: